US/EU Inspections MRA: Lessons Learned And Challenges Ahead for FDA
Executive Summary
You may also be interested in...
FDA Approves Four More Member States For US-EU Inspections MRA
The landmark mutual recognition agreement is now operational between 12 EU member states and the US Food and Drug Administration.
Ex-US FDA Official Sklamberg On Park Doctrine Limits, Data Integrity
Courts may increasingly find limits on how far Park Doctrine tool can be ‘pushed,’ Sklamberg says in wide-ranging interview with the Pink Sheet. Former US FDA deputy commissioner for global regulatory operations and policy, now with law firm Akin Gump, also shares his views on the US-EU MRA to recognize each other’s inspections and data integrity.
Quotable: Top Experts On Policy Hot Topics
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.